chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: YF
Symptoms: Medication error, No adverse event, Product preparation error
Clinical narrative: one of vaccines was not reconstituted, the child received only diluent with no reported adverse event; Initial information received on 15-Jun-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 4 years old male patient who experienced one of Yellow Fever Vaccine [YF-VAX] was not reconstituted, the child received only diluent with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 14-Jun-2023, it was reported that 0.5ml dose of suspect Yellow Fever Vaccine Solution for injection (lot number and expiry: not reported) was not reconstituted and the patient received only diluent via intramuscular route in unknown administration site for immunization, with no reported adverse event (product preparation error) (latency: same day). Information on the batch number was requested.  Reportedly, Pharmacist stated that yesterday, a family came in to have their children receive the YF-Vax prior to travel. But due to HCP error, one child received the YF-VAX, the other child received only diluent. The administering pharmacist does not know which child got the reconstituted vaccine and which received diluent only.  No lab data was reported.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event one of vaccines was not reconstituted, the child received only diluent with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.5
Sex: U
Vaccine: UNK
Symptoms: Medication error, No adverse event, Single component of a two-component product administered
Clinical narrative: only the liquid component of Pentacel was administered to patient with no reported adverse event; Initial information received on 15-Jun-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 6 months old and unknown gender patient who reported only the liquid component of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel (VERO)] was administered to patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection (lot number, strength, dose, expiry date not reported) via unknown route in unknown administration site for immunization.  On an unknown date the patient reported only the liquid component of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine was administered to patient with no reported adverse event (single component of a two-component product administered) (latency: same day).  It was reported "wanted to know if they can revaccinate the patient".  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: IPV
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: administration of 5mL IPOL to a patient instead of the 0.5mL standard dose with no reported adverse event; Initial information received on 15-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 4 years old male patient who had administration of 5ml IPV (VERO) [IPOL] instead of the 0.5ml standard dose with no reported adverse event  The patient's past medical history, medical treatment(s) and family history were not provided. No other vaccines were taken by the patient.  On 15-Jun-2023, the patient received a dose 1 of suspect poliomyelitis vaccine (inactivated) IPV (VERO) Suspension for injection (lot V1B901M) (with an unknown strength and expiry date) via unknown route in the right thigh for Immunization with dose 5ml total instead of the 0.5ml standard dose with no reported adverse event (incorrect dose administered) (latency- same day)  Reportedly, Medical assistant (MA)called reporting one of the nurses at the doctor's office injected the full 5mL IPOL to a patient instead of the 0.5mL standard dose. MA wanted to know what to do next, what is going to happen with the patient, and if there's something they should monitor?   Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 5.0
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: temperature excursion for IPOL as fridge left opened a little too long, Max/low temperature reached: 48.8F for a Duration of 40mins with no reported adverse event; After excursion vaccine was administered to a patient with no reported adverse event; Initial information received on 15-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 5 years old female patient and reporter reported temperature excursion for poliomyelitis vaccine (inactivated) IPV (VERO) [IPOL] as frdge left opened a little too long, max/low temperature reached: 48.8f for a duration of 40mins with no reported adverse event and after excursion vaccine was administered to a patient with no reported adverse event.                                                                                                           0 The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included varicella zoster vaccine live (OKA/MERCK) (Varivax [Varicella zoster vaccine live (OKA/MERCK)]) for Prophylactic vaccination.  On 13-Jun-2023, the patient received a Standard dose 1 of punctured poliomyelitis vaccine (inactivated) IPV (VERO) Suspension for injection at a dose of 0.5 ml total (lot V1A024M, expiry date- 17-FEB-2024) via intramuscular route in unknown administration site for Immunization.  Caller reported temperature excursion for poliomyelitis vaccine (inactivated) IPV (VERO) as fridge left opened a little too long, max/low temperature reached: 48.8f for a duration of 40mins with no reported adverse event (product storage error) (unknown latency) and after excursion vaccine was administered on 13-Jun-2023 to a patient with no reported adverse event (poor quality product administered) (latency- same day).  Reportedly, Human error was involved, and caller is asking how to proceed.  Action taken was not applicable  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Feeling hot, Injection site warmth, Peripheral swelling
Clinical narrative: Pt called complaining of swollen arm (size of "tennis ball" and feeling of warmth underneath the injection site (no reaction at injection site) the day after vaccination which was 6/16/23. Pt said she has been taking extra strength Tylenol for discomfort, and that swelling is slightly better than Saturday but still feels warm.
Age: 56.0
Sex: F
Vaccine: FLUR4
Symptoms: Expired product administered
Clinical narrative: Pt. came into the clinic at  230pm and I drew up vaccine and gave in L arm at 245PM. Went back to my desk after  left and realized the expiration date was 6/14/23, not 6/23/23.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased
Clinical narrative: Patient believes the Shingrix vaccine has caused her to not be able to raise her arm above her right shoulder.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse outcomes reported. Vaccine administered was passed the Beyond Use Date, as this date was misunderstood by clinic staff.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased
Clinical narrative: Patient believes the Shingrix vaccine has caused her to not be able to raise her arm above her LEFT shoulder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was accidently given 2 doses of HPV vaccine instead of 1 , patient experienced no symptoms after injections while in office.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Intracranial pressure increased, Postural orthostatic tachycardia syndrome
Clinical narrative: Diagnosed with POTS. INTERCRANIAL HYPERTENTION...ALLERGIC REACTIONS
Age: 25.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Peripheral swelling
Clinical narrative: patient reported itching and swelling/redness in arm below administration site (lower forearm) about 10 minutes after administration. Patient was given 25mg diphenhydramine and monitored. Issue resolved and patient was released from care at 12:18pm.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Back pain, Fatigue, Pain in extremity
Clinical narrative: Patient is a 51 year old female with PMH HTN, DM2 who presents for low back pain. S/p Moderna COVID booster 4 days ago. Felt fatigued the first two days with some arm soreness. These were similar symptoms to previous vaccinations with Moderna. Fatigue and arm soreness have improved. Yesterday onset of low back pain, worse today. Midline low spine. 5/10. Trying ibuprofen, heating pad with moderate relief. Denies trauma, falls. No saddle anesthesia or change in baseline stress incontinence of bladder. Denies change in BMs, bowel incontinence, extremity weakness/numbness. Denies burning/frequency of urination.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Bacterial infection, Blood test abnormal, Chest X-ray, Cough
Clinical narrative: Daily fever up to 101.4, severe cough, fatigue, no appetite, night sweats, weakness from June 2 through June 9. Visited emergency clinic 6/9 .
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Decreased appetite, Fatigue, Night sweats, Pyrexia
Clinical narrative: Daily fever up to 101.4, severe cough, fatigue, no appetite, night sweats, weakness from June 2 through June 9. Visited emergency clinic 6/9 .
Age: 0.58
Sex: M
Vaccine: DTPPVHBHPB, PNC13, RV5
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Within 24 hours of vaccine admin the infant developed V&D Vomiting resolved w/in 48 hours diarrhea still occuring 7 days later
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site rash, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: 24 hours after DTAP-IPV, developed red, raised rash around injection site. Very itchy, not painful. No other symptoms.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Vaccine given 6/17/23. On 6/18/23 pt developed red, itchy rash in the middle of the night. She took benadryl around the clock with no improvement. Came back to clinic on 6/19/23. Rash has improved today 6/19/23 & prescribed Triamcinolone cream.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer Adult lot # FL3198 expired vaccine given to patient The lable on the box stated vaccine expired 2/29/2022 Per staff this lot# expired 2/3/22
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Blood glucose increased, Dizziness, Hypotension, Laboratory test normal, Loss of consciousness
Clinical narrative: Passed out in restaurant, ended up overnight in hospital.
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Scan normal
Clinical narrative: Passed out in restaurant, ended up overnight in hospital.
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Cardiac function test, Loss of consciousness
Clinical narrative: Passed out in restaurant, ended up overnight in hospital.
Age: 51.0
Sex: F
Vaccine: YF, YF
Symptoms: Fatigue, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: color of the swelling area is unknown to the reporter but that the area is a little itchy; swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day; feeling fatigued; Initial information received on 14-Jun-2023 regarding an unsolicited valid non-serious case received from a nurse.  This case involves 51 years old female patient for whom color of the swelling area is unknown to the reporter but that the area is a little itchy, swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day and feeling fatigued after receiving vaccine yellow fever vaccine [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included typhoid vaccine live oral for Prophylactic vaccination.  On 08-Jun-2023, the patient received a standard dose of suspect yellow fever vaccine Solution for injection at a dose of 0.5 ml total (lot UJ819AA, expiry date- 18-APR-2024) via subcutaneous route in the left arm for Immunization   On 11-Jun-2023, (latency- 3 days ), the patient developed a non-serious event of color of the swelling area is unknown to the reporter but that the area is a little itchy (vaccination site pruritus), swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day (vaccination site swelling) and feeling fatigued (fatigue) following the administration of yellow fever vaccine.  Relevant laboratory test results included: Physical examination - On 11-Jun-2023: [swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm]  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events  At time of reporting, the outcome was Not Recovered / Not Resolved for all the events.; Sender's Comments:  US-SA-2023SA184227:01653953
Age: 51.0
Sex: F
Vaccine: YF, YF
Symptoms: Fatigue, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: color of the swelling area is unknown to the reporter but that the area is a little itchy; swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day; feeling fatigued; Initial information received on 14-Jun-2023 regarding an unsolicited valid non-serious case received from a nurse.  This case involves 51 years old female patient for whom color of the swelling area is unknown to the reporter but that the area is a little itchy, swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day and feeling fatigued after receiving vaccine yellow fever vaccine [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included typhoid vaccine live oral for Prophylactic vaccination.  On 08-Jun-2023, the patient received a standard dose of suspect yellow fever vaccine Solution for injection at a dose of 0.5 ml total (lot UJ819AA, expiry date- 18-APR-2024) via subcutaneous route in the left arm for Immunization   On 11-Jun-2023, (latency- 3 days ), the patient developed a non-serious event of color of the swelling area is unknown to the reporter but that the area is a little itchy (vaccination site pruritus), swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day (vaccination site swelling) and feeling fatigued (fatigue) following the administration of yellow fever vaccine.  Relevant laboratory test results included: Physical examination - On 11-Jun-2023: [swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm]  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events  At time of reporting, the outcome was Not Recovered / Not Resolved for all the events.; Sender's Comments:  US-SA-2023SA184227:01653953
Sex: F
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: administered on 08/07/2003; administered on 01/30/2003; This spontaneous report has been received from an other health professional, via a medical record from a case in litigation for Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (MARRS # 2303USA000299), concerning 1-day-old female patient.  Concurrent condition and medical history were not reported. Concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) tetanus vaccine toxoid (INFANRIX), hib vaccine (HIB), measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II) and polio vaccine inact (IPV).   On 04-JUN-2002, the patient was vaccinated with the first dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). On 30-JAN-2003, the patient was vaccinated with the second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (Inappropriate schedule of product administration). On 07-AUG-2003, the patient was vaccinated with the third dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (Inappropriate schedule of product administration).  This is one of several reports concerning the same patient.; Sender's Comments:  US-009507513-2303USA000299: US-009507513-2306USA002955:
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; Shingles; This serious case was reported by a nurse via sales rep and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included multiple sclerosis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-JUN-2023 This reporter had a question about one of her patient's with MS (Multiple sclerosis) who appeared to be presenting with shingles despite previously being vaccinated with Shingrix. The reporter shared that the patient had what she thought looked like shingles.  The reporter agreed to follow up from GlaxoSmithKline. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Age: 93.0
Sex: F
Vaccine: TDAP
Symptoms: Incorrect route of product administration, Medication error, Peripheral swelling
Clinical narrative: swelling on the forearm; administering it to a 93 year old patient intradermally; Initial information received on 15-Jun-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 93 years old female patient who had swelling on the forearm and administering it to a 93 year old patient intradermally after receiving vaccine diphtheria-2/tetanus/5 ac pertussis vaccine [adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 14-Jun-2023, the patient received a dose 1 0.5 ml once of suspect diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection, (unknown strength, expiration date), lot U7671AA via intradermal route in the left arm for immunisation.  On 14-JUN-2023 the patient developed a non-serious swelling on the forearm (peripheral swelling) and administering it to a 93 year old patient intradermally (incorrect route of product administration) (latency: same day).  Lab data was not reported.  Action taken was not applicable.  The patient was treated with FLUOCINONIDE (FLUOCINONIDE) for Peripheral swelling.  Outcome: Unknown for all the events  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain, Swelling
Clinical narrative: soreness; redness; swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), ERYTHEMA (redness) and SWELLING (swelling) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A, 029A21A, 071F21A and 048L21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (soreness), ERYTHEMA (redness) and SWELLING (swelling). At the time of the report, PAIN (soreness), ERYTHEMA (redness) and SWELLING (swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. Patient reported that they received all Moderna vaccines, and experienced with them soreness, redness and swelling, the expected side effects. No treatment medication were provided.   This case was linked to MOD-2023-729251 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2023: Live Follow up received contains No New Information
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal behaviour, Alopecia, Emotional distress, Full blood count, Laboratory test
Clinical narrative: Unusual behavior ( I passed out in a restaurant immediately following us both receiving the vaccine. Her response was totally different than her usual reaction to a stressful situation.). The next day, 02/02/2023, she began shedding hair. Within 3 weeks she had lost all of her body hair, scalp, eyebrows, eyelashes, nose hair,etc.  This has caused her incredible stress and emotional pain. The hair has not yet returned. She has undergone numerous tests and seen several different doctors, as yet to no avail.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Madarosis, Stress, Thyroid function test
Clinical narrative: Unusual behavior ( I passed out in a restaurant immediately following us both receiving the vaccine. Her response was totally different than her usual reaction to a stressful situation.). The next day, 02/02/2023, she began shedding hair. Within 3 weeks she had lost all of her body hair, scalp, eyebrows, eyelashes, nose hair,etc.  This has caused her incredible stress and emotional pain. The hair has not yet returned. She has undergone numerous tests and seen several different doctors, as yet to no avail.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Respiratory failure, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/18/2023  &   3/18/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Hepatitis C test negative, Mobility decreased, Musculoskeletal discomfort, Rheumatoid factor negative
Clinical narrative: I began to notice my left ankle seemed sprained, but I had not injured it . I then began to have a struggle to just stand up and move as if I had aged 25 years since my first vaccine .I had three.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Blood test, Electroneuromyography, Facial paralysis, Headache
Clinical narrative: When I first received the shot, I experienced a feeling of being sick which consisted of fever, headache, body aches and soreness around the injection site.  After the shot, I began to experience drooping in my right eye which would eventually close completely.  I sought out a neurologist who diagnosed me with an autoimmune disease called myasthenia gravis.  I have also experienced several episodes of kidney stones and muscle/nerve pain.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Magnetic resonance imaging, Malaise, Myalgia, Myasthenia gravis
Clinical narrative: When I first received the shot, I experienced a feeling of being sick which consisted of fever, headache, body aches and soreness around the injection site.  After the shot, I began to experience drooping in my right eye which would eventually close completely.  I sought out a neurologist who diagnosed me with an autoimmune disease called myasthenia gravis.  I have also experienced several episodes of kidney stones and muscle/nerve pain.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Nephrolithiasis, Nerve conduction studies, Neuralgia, Pain, Pyrexia
Clinical narrative: When I first received the shot, I experienced a feeling of being sick which consisted of fever, headache, body aches and soreness around the injection site.  After the shot, I began to experience drooping in my right eye which would eventually close completely.  I sought out a neurologist who diagnosed me with an autoimmune disease called myasthenia gravis.  I have also experienced several episodes of kidney stones and muscle/nerve pain.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: When I first received the shot, I experienced a feeling of being sick which consisted of fever, headache, body aches and soreness around the injection site.  After the shot, I began to experience drooping in my right eye which would eventually close completely.  I sought out a neurologist who diagnosed me with an autoimmune disease called myasthenia gravis.  I have also experienced several episodes of kidney stones and muscle/nerve pain.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Facial paresis, Hypotension
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY HYPOTENSION RIGHT FACIAL MUSCLE WEAKNESS
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Embolic stroke, Hypotension, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY HYPOTENSION 2/3/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aspiration, COVID-19, COVID-19 pneumonia, Death
Clinical narrative: Presents with SOB & low oxygen, from nursing home where he was dx with COVID 2 days prior. Had an aspiration event at PRIVACY which resulted in pneumonia. RA o2 SAT 52%; placed on BiPAP. Admitted for severe COVID pneumonia with acute hypoxic respiratory failure. Tx: abx, O2, steriods, outside the window for antiviral therapy per ID; pt was a DNR & required NIPPV & optiflow. Plan was to transition to inpatient hospice, however, pt expired the day prior to transition.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Intermittent positive pressure breathing, Mechanical ventilation, Oxygen saturation decreased, Pneumonia
Clinical narrative: Presents with SOB & low oxygen, from nursing home where he was dx with COVID 2 days prior. Had an aspiration event at PRIVACY which resulted in pneumonia. RA o2 SAT 52%; placed on BiPAP. Admitted for severe COVID pneumonia with acute hypoxic respiratory failure. Tx: abx, O2, steriods, outside the window for antiviral therapy per ID; pt was a DNR & required NIPPV & optiflow. Plan was to transition to inpatient hospice, however, pt expired the day prior to transition.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy
Clinical narrative: Presents with SOB & low oxygen, from nursing home where he was dx with COVID 2 days prior. Had an aspiration event at PRIVACY which resulted in pneumonia. RA o2 SAT 52%; placed on BiPAP. Admitted for severe COVID pneumonia with acute hypoxic respiratory failure. Tx: abx, O2, steriods, outside the window for antiviral therapy per ID; pt was a DNR & required NIPPV & optiflow. Plan was to transition to inpatient hospice, however, pt expired the day prior to transition.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bronchitis, COVID-19, Fatigue, Malaise
Clinical narrative: I had a sore arm and fatigued for about two days after receiving the vaccine. I began not feeling well on 01/31/2023 with sneezing and sore throat. I tested positive for COVID-19 on 02/02/2023. I contacted my doctor and got a prescription for prednisone and an antibiotic. I also had bronchitis too. As of today, I am feeling better but for four months since having COVID-19, I had extreme fatigue and really bad joint pain.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I had a sore arm and fatigued for about two days after receiving the vaccine. I began not feeling well on 01/31/2023 with sneezing and sore throat. I tested positive for COVID-19 on 02/02/2023. I contacted my doctor and got a prescription for prednisone and an antibiotic. I also had bronchitis too. As of today, I am feeling better but for four months since having COVID-19, I had extreme fatigue and really bad joint pain.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT FEMORAL VEIN
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Anaemia, Blood iron decreased, Blood test abnormal, Ear infection
Clinical narrative: I took her to the doctor at the end of April due to her complaining of sore throat, a headache and stomach pains. They did a strep test which came back negative. We went back a week following due to her complaining of the same symptoms as well as pale color and ear pain. She had an ear infection, and her doctor ordered a blood test on 05/01/2023 due to her skin paleness. Her iron levels were significantly so we were advised to return some weeks following after giving iron supplements to see if they would rise. We went in for a follow-up appointment on 06/14/2023 for complete blood count test and Celiac disease panel test. She was still anemic even after a month of taking supplements and the Celiac test came back positive for PTG. She had a pediatrician appointment yesterday where we were suggested to visit a gastroenterologist for a biopsy appointment, but in the meantime, she was suggested to begin a gluten-free diet until then.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Full blood count abnormal, Headache, Laboratory test abnormal, Mineral supplementation
Clinical narrative: I took her to the doctor at the end of April due to her complaining of sore throat, a headache and stomach pains. They did a strep test which came back negative. We went back a week following due to her complaining of the same symptoms as well as pale color and ear pain. She had an ear infection, and her doctor ordered a blood test on 05/01/2023 due to her skin paleness. Her iron levels were significantly so we were advised to return some weeks following after giving iron supplements to see if they would rise. We went in for a follow-up appointment on 06/14/2023 for complete blood count test and Celiac disease panel test. She was still anemic even after a month of taking supplements and the Celiac test came back positive for PTG. She had a pediatrician appointment yesterday where we were suggested to visit a gastroenterologist for a biopsy appointment, but in the meantime, she was suggested to begin a gluten-free diet until then.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pallor, Streptococcus test negative
Clinical narrative: I took her to the doctor at the end of April due to her complaining of sore throat, a headache and stomach pains. They did a strep test which came back negative. We went back a week following due to her complaining of the same symptoms as well as pale color and ear pain. She had an ear infection, and her doctor ordered a blood test on 05/01/2023 due to her skin paleness. Her iron levels were significantly so we were advised to return some weeks following after giving iron supplements to see if they would rise. We went in for a follow-up appointment on 06/14/2023 for complete blood count test and Celiac disease panel test. She was still anemic even after a month of taking supplements and the Celiac test came back positive for PTG. She had a pediatrician appointment yesterday where we were suggested to visit a gastroenterologist for a biopsy appointment, but in the meantime, she was suggested to begin a gluten-free diet until then.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Partial seizures
Clinical narrative: FOCAL MOTOR SEIZURE
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Hypotension
Clinical narrative: ACUTE NON ST ELEVATION MI HYPOTENSION
Sex: F
Vaccine: HEP
Symptoms: Blood culture negative, C-reactive protein increased, CSF culture negative, CSF test normal, Culture urine negative
Clinical narrative: Approximately 8  hours after receiving first dose of Hepatitis B vaccine baby developed fever of 101.3 temporally.  Temperature rechecked rectally and was 100.8. Baby was also fussy when laid down . Due to baby's age and onset of new fever, baby was sent to ED for evaluation and full sepsis work-up.  Hospitalized
Sex: F
Vaccine: HEP
Symptoms: Differential white blood cell count, Full blood count, Gastrointestinal pathogen panel, Infant irritability, Leukopenia
Clinical narrative: Approximately 8  hours after receiving first dose of Hepatitis B vaccine baby developed fever of 101.3 temporally.  Temperature rechecked rectally and was 100.8. Baby was also fussy when laid down . Due to baby's age and onset of new fever, baby was sent to ED for evaluation and full sepsis work-up.  Hospitalized
Sex: F
Vaccine: HEP
Symptoms: Lumbar puncture, Metabolic function test, Pyrexia, Respiratory pathogen panel, Urine analysis normal
Clinical narrative: Approximately 8  hours after receiving first dose of Hepatitis B vaccine baby developed fever of 101.3 temporally.  Temperature rechecked rectally and was 100.8. Baby was also fussy when laid down . Due to baby's age and onset of new fever, baby was sent to ED for evaluation and full sepsis work-up.  Hospitalized
Sex: F
Vaccine: HEP
Symptoms: White blood cell count decreased
Clinical narrative: Approximately 8  hours after receiving first dose of Hepatitis B vaccine baby developed fever of 101.3 temporally.  Temperature rechecked rectally and was 100.8. Baby was also fussy when laid down . Due to baby's age and onset of new fever, baby was sent to ED for evaluation and full sepsis work-up.  Hospitalized
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Bowel movement irregularity, Computerised tomogram, Decreased appetite
Clinical narrative: In the few weeks before my Urgent care center visit I had lost strength, had irregular bowell movements and loss of appetite.  I was put on Miralax at the Urgent care center visit.  I had all the side effects with no benefits so I discontinued use after two and one half weeks.  I met with my PCP on 20MAR2023 I was given a blood profile, ultrasound and a  CT scan. Pancreatic cancer was diagnosed.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pancreatic carcinoma, Ultrasound scan
Clinical narrative: In the few weeks before my Urgent care center visit I had lost strength, had irregular bowell movements and loss of appetite.  I was put on Miralax at the Urgent care center visit.  I had all the side effects with no benefits so I discontinued use after two and one half weeks.  I met with my PCP on 20MAR2023 I was given a blood profile, ultrasound and a  CT scan. Pancreatic cancer was diagnosed.
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA ANGINA, UNSPECIFIED
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Breast cyst, Exposure to SARS-CoV-2, Fatigue, Mammogram abnormal, Rash
Clinical narrative: I was really tired for about two days after receiving the vaccine. I had a regular scheduled mammogram in 09/2022. In 12/2022, I was notified that I have a small cyst in my left breast. No action required. Also in 12/2022, I developed hives that was all over my body. I had been exposed to COVID-19 but I tested negative. I have seen several doctors and they not believe that it is due to allergies, but they think it's COVID-19 related. I have been on antihistamine which helps but I still have random breakouts. I have noticed that heat will make it flareup.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Temperature intolerance, Urticaria
Clinical narrative: I was really tired for about two days after receiving the vaccine. I had a regular scheduled mammogram in 09/2022. In 12/2022, I was notified that I have a small cyst in my left breast. No action required. Also in 12/2022, I developed hives that was all over my body. I had been exposed to COVID-19 but I tested negative. I have seen several doctors and they not believe that it is due to allergies, but they think it's COVID-19 related. I have been on antihistamine which helps but I still have random breakouts. I have noticed that heat will make it flareup.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Epilepsy, Obstructive sleep apnoea syndrome
Clinical narrative: EPILEPSY, UNSPECIFIED OBSTRUCTIVE SLEEP APNEA
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: Patient was given an MMR vaccine that was expired by 1 day.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Myalgia
Clinical narrative: Redness below the injection site, pain in right bicep for 3 months post injection
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION ACUTE RESPIRATORY FAILURE 11/15/2022,  1/4/2023,  2/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 88.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia
Clinical narrative: HYPOTENSION HYPOXIA
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Rash, Vomiting
Clinical narrative: Per patient report:  "The symptoms started the day after the shot, right when I woke up in the morning. The rash stayed for 5 ish days, the vomiting stayed around for 2. I was then at the beach and the rash seemed to worsen when I was in the sun so I stayed out of it for 3 more days and then everything calmed down"
Age: 34.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The Moderna Bivalent Vaccine had expired on 5-19-2023. Inmate had signs and symptoms. And no adverse outcomes to date.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Psoriasis
Clinical narrative: I did not have an adverse reaction to the vaccine. Within about two weeks, I developed psoriasis on my back. I have never had this before. I went to my dermatologist and began taking medication to control it. As of today, I am feeling better with no symptoms.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 78.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Pain, Pain in extremity
Clinical narrative: 2 Days after the shot patient reported soreness in the arm.  Patient is now reporting a shooting pain on the arm as of 6/19/23
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: I21.4 ACUTE NON ST ELEVATION MI 4/28/2023 ACUTE NON ST ELEVATION MI
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT POPLITEAL VEIN
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Partial seizures
Clinical narrative: G40.109 PARTIAL EPILEPSY 2/2/2023 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 5/2/2023 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/21/2023 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Asthenia
Clinical narrative: I21.19 ACUTE ST ELEVATION MI, INFERIOR WALL 3/22/2023 ACUTE ST ELEVATION MI, INFERIOR WALL I21.19 ACUTE ST ELEVATION MI, INFERIOR WALL 3/22/2023 WEAKNESS
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Moderna Bivalent  Vaccine had expired on 5-19-2023. Inmate had no sign and symptoms. no adverse outcomes to date.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Coagulopathy, Hypotension, Lymphoproliferative disorder, Peripheral T-cell lymphoma unspecified
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERNICIOUS ANEMIA I95.9 HYPOTENSION 3/29/2023 PERNICIOUS ANEMIA D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN I95.9 HYPOTENSION 3/29/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 LYMPHOPROLIFERATIVE DISORDER I95.9 HYPOTENSION 3/29/2023 LYMPHOPROLIFERATIVE DISORDER D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN I95.9 HYPOTENSION 3/29/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 ANEMIA I95.9 HYPOTENSION 3/29/2023 ANEMIA
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pernicious anaemia
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERNICIOUS ANEMIA I95.9 HYPOTENSION 3/29/2023 PERNICIOUS ANEMIA D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN I95.9 HYPOTENSION 3/29/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 LYMPHOPROLIFERATIVE DISORDER I95.9 HYPOTENSION 3/29/2023 LYMPHOPROLIFERATIVE DISORDER D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN I95.9 HYPOTENSION 3/29/2023 PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED TYPE, SPLEEN D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/2/2023 ANEMIA I95.9 HYPOTENSION 3/29/2023 ANEMIA
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ANGIOEDEMA, INIT ANGIOEDEMA, SUBSEQ ANGIOEDEMA, SEQUELA
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Moderna Bivalent Vaccine had expired on 5-19-2023. Inmate had no signs/symptoms. And No adverse outcomes to date.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Immediate post-injection reaction, Laboratory test
Clinical narrative: My symptoms started on 03/15/2021 I started to feel dizzy and blood pressure was elevated right after the injection.  I was prescribed Hydrochlorothiazide for my symptoms.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Moderna Bivalent Vaccine had expired on 5-19-2023. Inmate had no signs/Symptoms . No adverse outcomes to date.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Moderna Bivalent Vaccine had expired 5-18-2023. Inmate had no signs/ symptoms. And no adverse outcomes to date
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Moderna Bivalent Vaccine had expired on 5-19-2023. The inmate had no signs and symptoms. No adverse outcome to this date.
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral, Symptom recurrence
Clinical narrative: PERIPHERAL NEUROPATHY 12/21/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ischaemic stroke, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 2/13/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 0.17
Sex: F
Vaccine: UNK
Symptoms: Dyskinesia
Clinical narrative: Pt. got her 2 month vaccines and was noted to have abnormal movements bilaterally.   She was taken to the hospital and monitored for 1 day and was discharged home as the movements stopped.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE ST ELEVATION MI, UNSPECIFIED